News
November 2021
June 2019
- AIBL participant information day 2019. Audio recording.
November 2016
September 2014
- AIBL was a finalist in the 2014 Eureka Prize for Excellence in Interdisciplinary Scientific Research. Congratulations to the winners – the University of Melbourne SEARCH (South-Eastern Australian Recent Climate History) team. Watch the AIBL finalist video below.
August 2014
- CSIRO scientists Shaun Frost, Yogi Kanagasingam and Lance Macaulay in the Medical Journal of Australia (MJA) on Ocular biomarkers for neurodegenerative and systemic disease.
- CSIRO news post The spice is right: how curry and the cloud may improve Alzheimer’s testing featuring AIBL research.
- AlzForum has a wrap up of last month’s Alzheimer’s Association International Conference (AAIC 2014, note presentation titles and presenters listed under the July 2014 entry below), which includes commentary on research from AIBL:
July 2014
- Dr Alan Rembach, study manager for AIBL’s Melbourne site, interviewed on ABC radio’s PM program on recent advances in blood-based biomarkers in Alzheimer’s disease.
- AIBL researchers, along with other researchers who analysed AIBL data, will be attending and presenting at the Alzheimer’s Association International Conference (AAIC 2014) in Washington, DC during July 2014:
- Brain beta-amyloid, Vascular Factors and Cognition: 54-month followup results from the AIBL Study – Dr Paul Yates
- Higher Aß burden in healthy ApoE-e4 carriers is associated with subjective memory complaints: Results from the flutemetamol and PiB AIBL cohorts. – Prof Chris Rowe
- Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal AD Trials: An AIBL Study – Dr Samantha Burnham
- APOE genotype-dependent effects of diet and physical activity on cognition and Alzheimer’s-related pathology: Data from the AIBL Study of Ageing – Dr Stephanie Rainey-Smith
- Predicting Alzheimer’s disease from a blood-based biomarker profile: Results from AIBL at 54 Months – Dr Samantha Burnham
- Genetic variation within genes of the sphingolipid metabolism pathway and their association with Alzheimer’s disease risk and related phenotypes – Assoc Prof Simon Laws
- Genetic analysis of the steroidogenesis pathway: Associations with Alzheimer’s disease risk and related phenotypes – Ms Tenielle Porter
- Novel candidate blood proteome markers of Alzheimer’s disease (AD) brain amyloid burden: a multiplex TMT-LC/MS-MS discovery approach. – Dr Chantal Bazenet
- Elevated blood HDL and HDL-associated lipoproteins in healthy controls who rapidly convert to Alzheimer’s disease in the AIBL cohort. – Dr Chris Fowler
- No gender differences in rates of conversion from cognitively healthy to MCI or AD over 18 months: Data from the AIBL cohort. – Dr Jo Robertson
- Longitudinal cognitive decline in the AIBL cohort: the role of APOE e4 status – Dr Jonathan Foster
- Retinal amyloid fluorescence imaging predicts cerebral amyloid burden and Alzheimer’s disease – Mr Shaun Frost
- Comparison of Three Normative Data Correction Approaches: A Cross Sectional Evaluation in the AIBL Study – Dr Samantha Burnham
February 2014
- Members of the AIBL Research Team Professor Colin Masters (Florey Institute of Neuroscience and Mental Health) and Dr Jurgen Fripp (Australian E-Health Research Centre, CSIRO) acknowledged for their contribution to Australian Academy of Science Inspiring smarter brain research in Australia report.
- Science and Industry Endowment Fund (SIEF) AIBL2 Final Report available via the SIEF web site.
January 2014
- CSIRO statistician and AIBL biomarker researcher Dr Sam Burnam profiled The statistician on a mission on the News@CSIRO blog.
September 2013
- Interviews with AIBL research leader Professor Ralph Martins, author of Understanding Alzheimer’s: the complete Australian guide to the management and prevention of Alzheimer’s
June 2013
- CSIRO’s Shawn Frost interviewed in Eye test for early Alzheimer’s detection (Channel 9 Victoria news story) on AIBL’s ocular biomarker research.
- NeuroVision Eye Test Part of Major Alzheimer’s Trial (Reuters story on AIBL research into ocular biomarkers).
- Medical Journal of Australia In Brief article The AIBL study: opening the presymptomatic window in Alzheimer disease written by AIBL researchers from CSIRO.
- Watch the Alzforum webinar “O Blood-Based Biomarker, Where Art Thou?”, which includes a presentation from CSIRO statistician and AIBL biomarker researcher Dr Sam Burnam.
March 2012
- Media associated with the RASAD 2012 conference
- Winning the Fight Together (Australian Ageing Agenda).
- Alzheimer’s Disease Experts Unite for Global Effort (SeniorAU)
- Australia Hosts Gobal Alzheimer’s Event (Aged Care Insite)
- Public lectures presented in association with the RASAD 2012 conference
- AIBL research leader Professor David Ames.
- Alzheimer’s Australia National President Ita Buttrose.
- Dr Maria Carrillo from the Alzheimer’s Association USA.
- AlzForum article on the global research landscape Age and Amyloid—What Has ApoE Got to Do With It?
February 2012
- AIBL research leader Professor Chris Rowe interviewed for AlzForum in Scan and Tell? Amyloid Imaging Confronts Disclosure Dilemma.
April 2011
- AIBL research leader Professor Chris Rowe interviewed for ABC Radio National’s Background Briefing program Dementia: into the daylight.
Partners and Supporters
